SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is seeing heavy discussion following mixed reactions to positive topline data from its AXPAXLI Phase 3 trial for wet AMD; while the primary superiority endpoint was met, investors are debating the drug's market differentiation and durability, leading to significant price volatility and renewed buyout speculation.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. ($INFQ) is trending as it begins trading under its new ticker after a de-SPAC merger, with the community actively discussing its strong quantum technology fundamentals, low share float, and significant growth potential despite current volatile market conditions and some brokerage update delays.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is experiencing significant momentum following positive Phase 3 trial results for its COMP360 psilocybin therapy in treatment-resistant depression, which demonstrated rapid, sustained efficacy and a favorable safety profile. The community is now buzzing about the accelerated timeline for a potential commercial launch and a newly cleared FDA path for PTSD trials, seeing this as a major step towards becoming a first-to-market psychedelic medicine.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending following its definitive agreement for Hapag-Lloyd to acquire the company at $35 per share in an all-cash deal, leading to fervent community discussion. Investors are actively weighing the significant arbitrage opportunity, the potential for a massive short squeeze due to high short interest, and the likelihood of continued dividends until the deal closes, while also considering potential regulatory hurdles from the Israeli government.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to heightened community debate surrounding recent disclosures from the Epstein files, which has intensified polarized sentiment about the company's valuation and its connection to broader political narratives.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Recent news of executive departures, significant workforce cuts, and exiting international markets is driving intense conversation around GEMI. The community is sharply divided between those calling it a "scam" after massive losses and others accumulating shares, betting on a turnaround fueled by its new prediction market license and high short interest.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending after securing an $11.5 million production contract from a key U.S. defense prime and being selected as the first qualified additive manufacturing vendor for the U.S. Army's ground vehicle systems. Despite these critical advancements in aerospace and defense, the community is actively debating the stock's immediate selling pressure while many are buying dips for anticipated long-term gains.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending after its Q1 earnings report, which highlighted a new acquisition and a multi-billion dollar expansion of its partnership with Google Cloud for AI security. While some investors see a compelling "buy the dip" opportunity in the cybersecurity leader, others express concern over the cost of acquisitions and the stock's recent underperformance amid broader software sector sentiment.

eToro Group Ltd. engages in the development, management, and provision of online trading software solutions and services. The firm's trading platform, eToro, allows users to trade financial instruments. It also enables non-professionals to trade in markets that were previously the exclusive arena of professional investors. The company was founded by Johnathan Alexander Assia, Guy Gamzu, David Ring, and Ronen Assia on December 14, 2006 and is headquartered in Bnei Braq, Israel.

Etoro Group Ltd - Ordinary Shares - Class A

eToro Group Ltd

eToro is trending following its strong Q4 earnings report, which highlighted a beat on profit estimates, growth in funded accounts and assets under administration, and an expanded share repurchase program. The community is actively discussing its perceived undervaluation and solid fundamentals, often comparing it favorably against other fintech platforms.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigen is drawing significant attention as its FDA-approved PAPZIMEOS therapy demonstrates durable patient responses and gains early commercial traction, intensified by recent institutional investments and a competitor's regulatory setback. The community is actively debating the stock's undervaluation, anticipating strong revenue growth, and pushing past persistent price resistance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stock Market Today, Feb. 17: Stocks fall after long Presidents' Day weekend

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Tuesday. This is TheStreet's Stock...

Danaher to buy Masimo in $9.9 billion deal in diagnostics push

The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close...

Futures Fall As AI Selloff Resumes

Futures Fall As AI Selloff Resumes US equity futures woke up after President's Day and chose to resume their selloff (after a modest bounce on Monday's holiday failed to hold) dragged by Tech, as the...

<ul class="summary-bullets"><li>Danaher anticipates the acquisition will add between $0.15 and $0.20 to adjusted earnings per share in the first full year after closing.</li><li>Masimo will operate as a standalone business inside Danaher’s Diagnostics unit.</li><li>The transaction is expected to close in the second half of 2026.</li></ul>Danaher Corp. (DHR) announced on Tuesday that it has agreed to acquire Masimo Corp. (MASI) in an all-cash transaction valued at roughly $9.9 billion, expanding its footprint in diagnostics and patient monitoring.&nbsp;The deal will entail Danaher paying $180 per share for Masimo. The acquisition price reflects about 18 times Masimo’s projected 2027earnings before interest, taxes, depreciation, and amortization (EBITDA).&nbsp;<h2 class="st-heading-2">Strategic Growth Benefits</h2>Danaher expects the transaction to strengthen its Diagnostics segment and deliver incremental earnings growth over time. Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/DHR">Danaher stock</a> traded over 6% lower, and&nbsp;<a href="https://stocktwits.com/symbol/MASI">Masimo stock</a> surged over 34% in Tuesday’s premarket.&nbsp;On Stocktwits, retail sentiment around Masimo shifted to ‘extremely bullish’ from ‘neutral’ territory the previous day. Message volume changed to ‘extremely high’ from ‘normal’ levels in 24 hours.&nbsp;Following completion, Masimo will operate as a standalone business inside Danaher’s Diagnostics unit, joining brands such as Radiometer, Leica Biosystems, Cepheid, and Beckman Coulter Diagnostics. Masimo specializes in pulse oximetry and other monitoring systems used in hospitals.<h2 class="st-heading-2">Financial Impact&nbsp;</h2>Danaher anticipates the acquisition will add between $0.15 and $0.20 to adjusted earnings per share in the first full year after closing, with the contribution rising to approximately $0.70 per share by year five.&nbsp;<blockquote>"Masimo's advanced sensor technology and AI-enabled monitoring bring powerful new capabilities to our diagnostics portfolio.”-Julie Sawyer Montgomery, Executive Vice President for Diagnostics, Danaher</blockquote>Under Danaher’s ownership, Masimo is forecast to generate more than $530 million in EBITDA by 2027. Management also expects to capture over $125 million in annual cost efficiencies and more than $50 million in annual revenue synergies within five years of closing.The transaction is expected to close in the second half of 2026.DHR stock has gained over 3% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/warner-bros-reopens-paramount-talks-as-netflix-merger-vote-looms/cZRWjFhR4uI">Warner Bros. Reopens Paramount Talks As Netflix Merger Vote Looms</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Danaher Corporation.

Danaher Deal Finalized: Company To Acquire Masimo For $9.9 Billion In  Cash

The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization. 

Equity

The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization. 


Danaher Strengthens Diagnostics Capabilities With $9.9 Bln Masimo Acquisition

(RTTNews) - Danaher Corp. (DHR), a science and technology innovator, announced Tuesday that it has entered into a definitive agreement to acquire Masimo Corp. (MASI) a specialty diagnostics provider...

Masimo to be Acquired by Danaher for $180.00 Per Share

Masimo Corporation (Nasdaq: MASI) (Masimo), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR...

Danaher To Acquire Masimo Corporation

Danaher To Acquire Masimo Corporation Danaher To Acquire Masimo Corporation PR Newswire WASHINGTON, Feb. 17, 2026 WASHINGTON, Feb. 17, 2026 /PRNewswire/ --Danaher Corporation (NYSE: DHR), a global...

Skandinaviska Enskilda Banken AB publ Has $56.10 Million Stock Position in Danaher Corporation $DHR

Skandinaviska Enskilda Banken AB publ increased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 113.8% in the third quarter, according to its most recent disclosure with the...

Danaher Corporation $DHR Holdings Raised by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. increased its stake in Danaher Corporation (NYSE:DHR - Free Report) by 9.9% during the third quarter, according to its most recent 13F filing with the Securities and...

Masimo Stock Soars As Danaher Closes In On Blockbuster Deal

Danaher approaches a $9.9 billion acquisition of Masimo following activist-led board changes and recent divestitures.read more...

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Danaher Corp.

Traders are reacting to Danaher's definitive agreement to acquire Masimo for $180 per share in cash, a deal valued at approximately $9.9 billion.

Danaher shares are down significantly while Masimo shares surged around 35% in pre-market trading following the acquisition announcement.

DHR
Danaher Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DHR News

DHRDanaher Corp.